Screening of dermatology drugs for aberrant use-patterns: An application of epidemiologic estimates and measures of inequality in drug use.
Thomas DelvinAnette BygumLars Christian LundJacob Harbo AndersenJesper HallasPublished in: British journal of clinical pharmacology (2024)
In Denmark, dermatology drugs are used primarily as anticipated, with minimal unexpected patterns. Specific follow-up is required to draw conclusions about inappropriate use. This approach demonstrates broad applicability for screening aberrant drug utilization.
Keyphrases